12 reports

Gene Therapy in CVMD

7012 7995 6236
  • EPIDEMIOLOGY - POMPE DISEASE

I think one collapsed in Phase I and one in Phase II.

  • Epidemiology
  • United States
  • AnGes MG, Inc.
  • Juventas Therapeutics, Inc.
  • ViroMed Co., Ltd.

There are seven PGF targeting drugs, six of which are fusion proteins and one is RNAi gene therapy.

  • Epidemiology
  • Novartis AG
  • Ophthotech Corporation
  • Regeneron Pharmaceuticals, Inc.
  • Roche Group

GENE THERAPY-BASED APPROACHES EXPECTED TO DRIVE PARKINSON' S DISEASE MARKET Gene therapy approaches are expected to emerge as an effective treatment for Parkinson' s disease.

  • Epidemiology
  • Hospital
  • AstraZeneca PLC
  • Lilly Endowment Inc.
  • Pfizer Inc.

BioMed Central Ltd, ##(##), p. ##. doi: ##. ##/ ##-##-##-##.

  • Epidemiology
  • India
  • United States
  • World
  • Forecast

BioMed Central Ltd, ##(##), p. ##. doi: ##. ##/ ##-##-##-##.

  • Epidemiology
  • Health Services
  • United States
  • World
  • Forecast

PLOS ONE; ##(##): ##-##.

  • Epidemiology
  • AstraZeneca PLC
  • Cerenis
  • Merck & Co., Inc.
  • The Medicines Company

Clinical Hypertension; ##(##): ##.

  • Epidemiology
  • Market Size
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi S.A.

Current Stem Cell Reports, ##: pp. ##-##. ##) Balani P (2018), Regulatory Environment for Cell and Gene Therapies.

  • Cardiovascular Disease
  • Cell Therapy
  • Epidemiology
  • United States
  • Market Size

UA=##& UA=##.

  • Epidemiology
  • Market Size
  • Gilead Sciences, Inc.
  • Novartis AG
  • Roche Group

ID=##.

  • Epidemiology
  • FirstString Research, Inc.
  • Organogenesis, Inc.
  • Osiris Therapeutics, Inc.
  • Smith & Nephew Plc

INTERESTINGLY, A NUMBER OF GENE THERAPY AGENTS ARE REPRESENTED IN BOTH THE PHASE II AND PHASE III PIPELINES.

  • Epidemiology
  • Sexually Transmitted Disease
  • Forecast
  • CEL-SCI Corporation
  • Merck & Co., Inc.

BIODRUGS: CLINICAL IMMUNOTHERAPEUTICS, BIOPHARMACEUTICALS AND GENE THERAPY; ##(##): ##-##.

  • Epidemiology
  • World
  • Bristol-Myers Squibb Company
  • Immunomedics, Inc.
  • MolMed S.p.A.